U.S. Markets closed
  • S&P 500

    4,551.68
    -23.11 (-0.51%)
     
  • Dow 30

    35,490.69
    -266.19 (-0.74%)
     
  • Nasdaq

    15,235.84
    +0.12 (+0.00%)
     
  • Russell 2000

    2,252.49
    -43.58 (-1.90%)
     
  • Gold

    1,798.50
    +5.10 (+0.28%)
     
  • EUR/USD

    1.1608
    +0.0005 (+0.0464%)
     
  • 10-Yr Bond

    1.5290
    -0.0900 (-5.56%)
     
  • Vix

    16.98
    +1.00 (+6.26%)
     
  • GBP/USD

    1.3739
    -0.0024 (-0.1731%)
     
  • USD/JPY

    113.8290
    -0.3000 (-0.2629%)
     
  • BTC-USD

    58,775.30
    -3,282.73 (-5.29%)
     
  • CMC Crypto 200

    1,405.87
    -68.46 (-4.64%)
     
  • FTSE 100

    7,253.27
    -24.35 (-0.33%)
     
  • Nikkei 225

    29,098.24
    -7.76 (-0.03%)
     

Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet

·2 min read
Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Aerie Pharmaceuticals missed the mark in a dry-eye disease test, leading AERI stock to plummet to a 10-month low Thursday.